Ductal Carcinoma in Situ, also known as noninfiltrating intraductal carcinoma, is related to comedo carcinoma and breast ductal carcinoma. An important gene associated with Ductal Carcinoma in Situ is TP53 (Tumor Protein P53), and among its related pathways/superpathways are Infectious disease and GPCR Pathway. The drugs Ondansetron and Sufentanil have been mentioned in the context of this disorder. Affiliated tissues include breast and lymph node, and related phenotypes are Decreased viability and growth/size/body region